Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Desmoid Tumors Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ...
-
Zurletrectinib demonstrated well-tolerated safety and promising antitumor activity in pediatric/adolescent patients with NTRK/ROS1-altered solid tumors.
-
Die Center Certification Ceremony fand am 4. Oktober 2025 anlässlich der Jahreskonferenz der European Association of Nuclear Medicine (EANM) in Barcelona statt. 9. Oktober 2025 – Wiesbaden,...
-
The Center Certification Ceremony took place during the ICPO Reception on the occasion of the EANM conference on Oct 4, 2025, in Barcelona. October 9, 2025 – Wiesbaden, Germany. The International...
-
Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has...
-
Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been...
-
DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for...
-
Die ICPO-Akkreditierung erfolgt gemäß internationalen Theranostik-Richtlinien, während die ICPO Academy for Theranostics die Partnerschaft von Anfang an stärkt. 31. Juli 2025 – Wiesbaden,...
-
ICPO accreditation following international theranostics guidelines and ICPO Academy for Theranostics will fuel the partnership right from start. July 31, 2025 – Wiesbaden, Germany, and Sao Paulo,...
-
Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of CAR/TCR/TIL Therapies in Oncology with Confidence" directory has been added to ResearchAndMarkets.com's...